Dr. Palmisano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-498-6205
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2021 - 2025
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2018 - 2021
- Vanderbilt University School of MedicineClass of 2018
- University of RochesterBS, BA, Biochemistry, Chemistry, Summa cum laude, Highest Honors, 2005 - 2009
Certifications & Licensure
- CA State Medical License 2019 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Genome-Wide Genetic Associations Prioritize Evaluation of Causal Mechanisms of Atherosclerotic Disease Risk.Thomas Quertermous, Daniel Yuhang Li, Chad S Weldy, Markus Ramste, Disha Sharma
Arteriosclerosis, Thrombosis, and Vascular Biology. 2024-02-01 - Another Use for Polygenic Risk Scores: Improving Risk Prediction for Heterozygous Familial Hypercholesterolemia.Brian T Palmisano, Joshua W Knowles
JACC. Advances. 2023-11-01 - 5 citationsHepatocyte Small Heterodimer Partner Mediates Sex-Specific Effects on Triglyceride Metabolism via Androgen Receptor in Male Mice.Brian T. Palmisano, Lin Zhu, Bridget Litts, Andreanna Burman, Sophia Yu
Metabolites. 2021-05-20
Press Mentions
- Primary Prevention in HypercholesterolemiaSeptember 30th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: